User login
SAN DIEGO - Patients with chronic venous disease who were treated surgically were significantly more likely to experience relief of symptoms than were those who underwent conservative therapy, results from a single-center study showed.
“The interventional treatment of varicose veins is considered to be medically necessary by insurance policies if the patient remains symptomatic after compression stockings or conservative therapy,” Dr. Fedor Lurie said at the annual meeting of the American Venous Forum. “This is despite the fact that little is known about symptoms of chronic venous disease. Even less known is how the symptoms of chronic venous disease react to treatment.”
Dr. Lurie and his colleague, Dr. Robert L. Kistner, prospectively studied 150 patients (59 men, 91 women; mean age 55 years) with CEAP class 2-4 primary chronic venous disease who were treated at the Kistner Vein Clinic in Honolulu during a 12-month period. (CEAP is a classification system based on the elements of Clinical severity, Etiology or cause, Anatomy, and Pathophysiology.) Initial treatment consisted of compression stockings and other conservative measures, after which patients chose whether to continue conservative treatment or undergo surgery.
Patients completed the Specific Quality of Life and Outcome Response-Venous (SQOR-V) assessment prior to the initial visit, after completion of conservative treatment, and at 1- and 12-month follow-up visits after surgical treatment. The quality of life and symptom score components of this tool were analyzed separately.
Following conservative treatment, symptom scores improved in 85 patients (57%), while quality of life scores improved in 111 patients (74%). Despite this improvement, 121 patients (81%) chose to undergo surgical treatment.
During the 1-month follow-up after surgical treatment, symptom scores improved in 97 patients (80%), while quality of life scores improved in 114 patients (94%).
Dr. Lurie also reported that 51 of 65 patients who did not improve after conservative treatment were treated surgically. Of those 51, only 30 (59%) improved after surgery.
Patients whose symptom scores improved after conservative treatment were 15.2 times more likely to have symptom relief at 1 month and 21.3 times more likely to have symptom relief at 1 year than were those who had no improvement in symptom scores. They were also 9.4 times more likely to have improved quality of life at 1 month and 4.3 times more likely to have improved quality of life at 1 year.
“The relief of symptoms by conservative therapy is a good predictor of successful surgical treatment,” said Dr. Lurie, who is also a clinical professor of vascular surgery at the University of Hawaii. “These findings contradict the present practice of insurance policies that interpret the success of conservative measures as a contraindication to surgical treatment, and provide evidence that those who respond favorably to conservative treatment are the ones who will benefit greatly from surgical elimination of the venous reflux.”
He concluded by noting that when the treatment goal is relief of symptoms, “success of conservative therapy should be considered an indication for surgical treatment, and the failure of conservative therapy should be an indication for reconsideration of the true cause of the symptoms.”
Dr. Lurie and Dr. Kistner said that they had no relevant financial disclosures.
This is an interesting study from the point of view of insurance reimbursement for the treatment of varicose veins. It confirms that conservative therapy with stockings will improve symptoms in many patients but they still want to undergo more definitive therapy. The reasons for this are not explained but I would suggest that most patients find wearing stockings inconvenient and also they just do not appreciate the cosmetic issues associated with stocking therapy. Further, I would suggest that although many patients complain about symptoms the predominant issue that drives them to undergo varicose veins removal remains cosmetic. As such, one wonders why insurance carriers should pay for cosmetic vein removal. In this age of skyrocketing health care costs I believe it behooves the vein specialist to truly evaluate their patients to decide whether the patient is using “symptoms” to get insurance to reimburse them for cosmetic vein treatments. If cosmetic issues are predominant then perhaps the patient should bear the cost themselves.
Russell H. Samson, M.D., is a physician in the practice of Samson, Showalter, Lepore, and Nair, and clinical associate professor of surgery, Florida State University.
This is an interesting study from the point of view of insurance reimbursement for the treatment of varicose veins. It confirms that conservative therapy with stockings will improve symptoms in many patients but they still want to undergo more definitive therapy. The reasons for this are not explained but I would suggest that most patients find wearing stockings inconvenient and also they just do not appreciate the cosmetic issues associated with stocking therapy. Further, I would suggest that although many patients complain about symptoms the predominant issue that drives them to undergo varicose veins removal remains cosmetic. As such, one wonders why insurance carriers should pay for cosmetic vein removal. In this age of skyrocketing health care costs I believe it behooves the vein specialist to truly evaluate their patients to decide whether the patient is using “symptoms” to get insurance to reimburse them for cosmetic vein treatments. If cosmetic issues are predominant then perhaps the patient should bear the cost themselves.
Russell H. Samson, M.D., is a physician in the practice of Samson, Showalter, Lepore, and Nair, and clinical associate professor of surgery, Florida State University.
This is an interesting study from the point of view of insurance reimbursement for the treatment of varicose veins. It confirms that conservative therapy with stockings will improve symptoms in many patients but they still want to undergo more definitive therapy. The reasons for this are not explained but I would suggest that most patients find wearing stockings inconvenient and also they just do not appreciate the cosmetic issues associated with stocking therapy. Further, I would suggest that although many patients complain about symptoms the predominant issue that drives them to undergo varicose veins removal remains cosmetic. As such, one wonders why insurance carriers should pay for cosmetic vein removal. In this age of skyrocketing health care costs I believe it behooves the vein specialist to truly evaluate their patients to decide whether the patient is using “symptoms” to get insurance to reimburse them for cosmetic vein treatments. If cosmetic issues are predominant then perhaps the patient should bear the cost themselves.
Russell H. Samson, M.D., is a physician in the practice of Samson, Showalter, Lepore, and Nair, and clinical associate professor of surgery, Florida State University.
SAN DIEGO - Patients with chronic venous disease who were treated surgically were significantly more likely to experience relief of symptoms than were those who underwent conservative therapy, results from a single-center study showed.
“The interventional treatment of varicose veins is considered to be medically necessary by insurance policies if the patient remains symptomatic after compression stockings or conservative therapy,” Dr. Fedor Lurie said at the annual meeting of the American Venous Forum. “This is despite the fact that little is known about symptoms of chronic venous disease. Even less known is how the symptoms of chronic venous disease react to treatment.”
Dr. Lurie and his colleague, Dr. Robert L. Kistner, prospectively studied 150 patients (59 men, 91 women; mean age 55 years) with CEAP class 2-4 primary chronic venous disease who were treated at the Kistner Vein Clinic in Honolulu during a 12-month period. (CEAP is a classification system based on the elements of Clinical severity, Etiology or cause, Anatomy, and Pathophysiology.) Initial treatment consisted of compression stockings and other conservative measures, after which patients chose whether to continue conservative treatment or undergo surgery.
Patients completed the Specific Quality of Life and Outcome Response-Venous (SQOR-V) assessment prior to the initial visit, after completion of conservative treatment, and at 1- and 12-month follow-up visits after surgical treatment. The quality of life and symptom score components of this tool were analyzed separately.
Following conservative treatment, symptom scores improved in 85 patients (57%), while quality of life scores improved in 111 patients (74%). Despite this improvement, 121 patients (81%) chose to undergo surgical treatment.
During the 1-month follow-up after surgical treatment, symptom scores improved in 97 patients (80%), while quality of life scores improved in 114 patients (94%).
Dr. Lurie also reported that 51 of 65 patients who did not improve after conservative treatment were treated surgically. Of those 51, only 30 (59%) improved after surgery.
Patients whose symptom scores improved after conservative treatment were 15.2 times more likely to have symptom relief at 1 month and 21.3 times more likely to have symptom relief at 1 year than were those who had no improvement in symptom scores. They were also 9.4 times more likely to have improved quality of life at 1 month and 4.3 times more likely to have improved quality of life at 1 year.
“The relief of symptoms by conservative therapy is a good predictor of successful surgical treatment,” said Dr. Lurie, who is also a clinical professor of vascular surgery at the University of Hawaii. “These findings contradict the present practice of insurance policies that interpret the success of conservative measures as a contraindication to surgical treatment, and provide evidence that those who respond favorably to conservative treatment are the ones who will benefit greatly from surgical elimination of the venous reflux.”
He concluded by noting that when the treatment goal is relief of symptoms, “success of conservative therapy should be considered an indication for surgical treatment, and the failure of conservative therapy should be an indication for reconsideration of the true cause of the symptoms.”
Dr. Lurie and Dr. Kistner said that they had no relevant financial disclosures.
SAN DIEGO - Patients with chronic venous disease who were treated surgically were significantly more likely to experience relief of symptoms than were those who underwent conservative therapy, results from a single-center study showed.
“The interventional treatment of varicose veins is considered to be medically necessary by insurance policies if the patient remains symptomatic after compression stockings or conservative therapy,” Dr. Fedor Lurie said at the annual meeting of the American Venous Forum. “This is despite the fact that little is known about symptoms of chronic venous disease. Even less known is how the symptoms of chronic venous disease react to treatment.”
Dr. Lurie and his colleague, Dr. Robert L. Kistner, prospectively studied 150 patients (59 men, 91 women; mean age 55 years) with CEAP class 2-4 primary chronic venous disease who were treated at the Kistner Vein Clinic in Honolulu during a 12-month period. (CEAP is a classification system based on the elements of Clinical severity, Etiology or cause, Anatomy, and Pathophysiology.) Initial treatment consisted of compression stockings and other conservative measures, after which patients chose whether to continue conservative treatment or undergo surgery.
Patients completed the Specific Quality of Life and Outcome Response-Venous (SQOR-V) assessment prior to the initial visit, after completion of conservative treatment, and at 1- and 12-month follow-up visits after surgical treatment. The quality of life and symptom score components of this tool were analyzed separately.
Following conservative treatment, symptom scores improved in 85 patients (57%), while quality of life scores improved in 111 patients (74%). Despite this improvement, 121 patients (81%) chose to undergo surgical treatment.
During the 1-month follow-up after surgical treatment, symptom scores improved in 97 patients (80%), while quality of life scores improved in 114 patients (94%).
Dr. Lurie also reported that 51 of 65 patients who did not improve after conservative treatment were treated surgically. Of those 51, only 30 (59%) improved after surgery.
Patients whose symptom scores improved after conservative treatment were 15.2 times more likely to have symptom relief at 1 month and 21.3 times more likely to have symptom relief at 1 year than were those who had no improvement in symptom scores. They were also 9.4 times more likely to have improved quality of life at 1 month and 4.3 times more likely to have improved quality of life at 1 year.
“The relief of symptoms by conservative therapy is a good predictor of successful surgical treatment,” said Dr. Lurie, who is also a clinical professor of vascular surgery at the University of Hawaii. “These findings contradict the present practice of insurance policies that interpret the success of conservative measures as a contraindication to surgical treatment, and provide evidence that those who respond favorably to conservative treatment are the ones who will benefit greatly from surgical elimination of the venous reflux.”
He concluded by noting that when the treatment goal is relief of symptoms, “success of conservative therapy should be considered an indication for surgical treatment, and the failure of conservative therapy should be an indication for reconsideration of the true cause of the symptoms.”
Dr. Lurie and Dr. Kistner said that they had no relevant financial disclosures.